Alzheimer's: New Study Challenges Plaque Theory

New research from the University of California, Riverside (UCR) is challenging a fundamental concept in Alzheimer's disease research. For decades, the focus has been on amyloid beta plaques forming outside nerve cells as the primary cause. However, this study suggests that the disease's earliest signs might actually originate within neurons themselves.

Scientists now propose that amyloid beta and another protein, tau, may interfere with each other inside nerve cells. They found that amyloid beta can bind to microtubules, structures crucial for cell transport, in a similar way to tau. This competition for binding sites could prevent tau from functioning correctly, disrupting the cell's internal transport system.

This proposed mechanism could represent a much earlier stage of Alzheimer's development than previously understood. If amyloid beta accumulates inside neurons, it might displace tau, destabilizing the cell's machinery. This disruption could then lead to tau clumping and abnormal cellular behavior, suggesting a broader issue within cells rather than solely protein buildup.

While this theory offers a plausible explanation, researchers emphasize it's a working model. The next critical step is to confirm if this process occurs in humans and how it correlates with cognitive decline. The findings could redirect future research toward understanding these intracellular protein interactions and developing novel therapeutic strategies targeting these early cellular disruptions.